Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
Clinical trial NCT06883136 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06883136
- Sponsor
- Qianfoshan Hospital
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-12
- Primary completion
- 2026-05-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.